301 related articles for article (PubMed ID: 29281854)
1. Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
Ziol M; Poté N; Amaddeo G; Laurent A; Nault JC; Oberti F; Costentin C; Michalak S; Bouattour M; Francoz C; Pageaux GP; Ramos J; Decaens T; Luciani A; Guiu B; Vilgrain V; Aubé C; Derman J; Charpy C; Zucman-Rossi J; Barget N; Seror O; Ganne-Carrié N; Paradis V; Calderaro J
Hepatology; 2018 Jul; 68(1):103-112. PubMed ID: 29281854
[TBL] [Abstract][Full Text] [Related]
2. Multiphase Liver MRI for Identifying the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma.
Mulé S; Galletto Pregliasco A; Tenenhaus A; Kharrat R; Amaddeo G; Baranes L; Laurent A; Regnault H; Sommacale D; Djabbari M; Pigneur F; Tacher V; Kobeiter H; Calderaro J; Luciani A
Radiology; 2020 Jun; 295(3):562-571. PubMed ID: 32228294
[TBL] [Abstract][Full Text] [Related]
3. Gadoxetic acid-enhanced MRI of macrotrabecular-massive hepatocellular carcinoma and its prognostic implications.
Rhee H; Cho ES; Nahm JH; Jang M; Chung YE; Baek SE; Lee S; Kim MJ; Park MS; Han DH; Choi JY; Park YN
J Hepatol; 2021 Jan; 74(1):109-121. PubMed ID: 32818570
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
[No Abstract] [Full Text] [Related]
5. Preoperative CT for Characterization of Aggressive Macrotrabecular-Massive Subtype and Vessels That Encapsulate Tumor Clusters Pattern in Hepatocellular Carcinoma.
Feng Z; Li H; Zhao H; Jiang Y; Liu Q; Chen Q; Wang W; Rong P
Radiology; 2021 Jul; 300(1):219-229. PubMed ID: 33973839
[TBL] [Abstract][Full Text] [Related]
6. ESM1 as a Marker of Macrotrabecular-Massive Hepatocellular Carcinoma.
Calderaro J; Meunier L; Nguyen CT; Boubaya M; Caruso S; Luciani A; Amaddeo G; Regnault H; Nault JC; Cohen J; Oberti F; Michalak S; Bouattour M; Vilgrain V; Pageaux GP; Ramos J; Barget N; Guiu B; Paradis V; Aubé C; Laurent A; Pawlotsky JM; Ganne-Carrié N; Zucman-Rossi J; Seror O; Ziol M
Clin Cancer Res; 2019 Oct; 25(19):5859-5865. PubMed ID: 31358545
[TBL] [Abstract][Full Text] [Related]
7. A multitask deep learning radiomics model for predicting the macrotrabecular-massive subtype and prognosis of hepatocellular carcinoma after hepatic arterial infusion chemotherapy.
He X; Li K; Wei R; Zuo M; Yao W; Zheng Z; He X; Fu Y; Li C; An C; Liu W
Radiol Med; 2023 Dec; 128(12):1508-1520. PubMed ID: 37801197
[TBL] [Abstract][Full Text] [Related]
8. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
9. Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid-enhanced magnetic resonance imaging.
Chen J; Xia C; Duan T; Cao L; Jiang H; Liu X; Zhang Z; Ye Z; Wu Z; Gao R; Shi Y; Song B
Eur Radiol; 2021 Oct; 31(10):7696-7704. PubMed ID: 33856520
[TBL] [Abstract][Full Text] [Related]
10. MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysis.
Kim TH; Woo S; Lee DH; Do RK; Chernyak V
Eur Radiol; 2024 Mar; ():. PubMed ID: 38507054
[TBL] [Abstract][Full Text] [Related]
11. Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.
Tsuchiya K; Komuta M; Yasui Y; Tamaki N; Hosokawa T; Ueda K; Kuzuya T; Itakura J; Nakanishi H; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Sakamoto M; Izumi N
Oncology; 2011; 80(3-4):278-88. PubMed ID: 21734420
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and Prognostic Ability of Contrast-Enhanced Unltrasound and Biomarkers in Hepatocellular Carcinoma Subtypes.
Xu W; Huang B; Zhang R; Zhong X; Zhou W; Zhuang S; Xie X; Fang J; Xu M
Ultrasound Med Biol; 2024 Apr; 50(4):617-626. PubMed ID: 38281888
[TBL] [Abstract][Full Text] [Related]
13. Albumin-bilirubin grade predicts the outcomes of liver resection versus radiofrequency ablation for very early/early stage of hepatocellular carcinoma.
Chong CC; Chan AW; Wong J; Chu CM; Chan SL; Lee KF; Yu SC; To KF; Johnson P; Lai PB
Surgeon; 2018 Jun; 16(3):163-170. PubMed ID: 28807570
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma.
Cho JY; Choi MS; Lee GS; Sohn W; Ahn J; Sinn DH; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW
Clin Mol Hepatol; 2016 Dec; 22(4):477-486. PubMed ID: 28081587
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis.
N'Kontchou G; Mahamoudi A; Aout M; Ganne-Carrié N; Grando V; Coderc E; Vicaut E; Trinchet JC; Sellier N; Beaugrand M; Seror O
Hepatology; 2009 Nov; 50(5):1475-83. PubMed ID: 19731239
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma.
Liu LL; Zhang SW; Chao X; Wang CH; Yang X; Zhang XK; Wen YL; Yun JP; Luo RZ
Cancer Immunol Immunother; 2021 Feb; 70(2):417-429. PubMed ID: 32770259
[TBL] [Abstract][Full Text] [Related]
17. Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD; Wu JC
J Clin Gastroenterol; 2012 Jan; 46(1):62-70. PubMed ID: 21934530
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
19. ESM-1 expression in stromal cells is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma.
Ziol M; Sutton A; Calderaro J; Barget N; Aout M; Leroy V; Blanc JF; Sturm N; Bioulac-Sage P; Nahon P; Nault JC; Charnaux N; N'kontchou G; Trinchet JC; Delehedde M; Seror O; Beaugrand M; Vicaut E; Ganne-Carrié N
J Hepatol; 2013 Dec; 59(6):1264-70. PubMed ID: 23928407
[TBL] [Abstract][Full Text] [Related]
20. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]